Get the Stockscreener App
2.40
3.19%
0.05
Inovio Pharmaceuticals Inc stock is traded at $2.40, with a volume of 520.76K.
It is up +3.19% in the last 24 hours and down -0.21% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.35
Open:
$2.35
24h Volume:
520.76K
Relative Volume:
0.34
Market Cap:
$127.57M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.3941
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
-2.61%
1M Performance:
-0.21%
6M Performance:
+26.30%
1Y Performance:
-55.50%
1-Day Range:
$2.35
$2.49
1-Week Range:
$2.31
$2.675
52-Week Range:
$1.30
$5.80
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.4006 | 124.89M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.44 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.71 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.88 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Inovio (INO) Finalizes BLA Submission for INO-3107 - GuruFocus
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PR Newswire
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsShort Setup & Safe Entry Momentum Stock Tips - newser.com
What RSI levels show for Inovio Pharmaceuticals Inc. (GBM) stock2025 Technical Overview & Growth Focused Stock Reports - newser.com
Is Inovio Pharmaceuticals Inc. (GBM) stock a fit for income portfoliosGap Down & Detailed Earnings Play Alerts - newser.com
Why Inovio Pharmaceuticals Inc. stock is a value investor pickWeekly Market Report & Precise Entry and Exit Recommendations - newser.com
Can Inovio Pharmaceuticals Inc. stock outperform in 2025 bull market2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Statistical indicators supporting Inovio Pharmaceuticals Inc.’s strengthJuly 2025 Intraday Action & Daily Oversold Bounce Ideas - newser.com
Price momentum metrics for Inovio Pharmaceuticals Inc. explainedBull Run & Capital Efficient Trading Techniques - newser.com
Strategies to average down on Inovio Pharmaceuticals Inc.Portfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Why hedge funds are buying Inovio Pharmaceuticals Inc. stockJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
What momentum indicators show for Inovio Pharmaceuticals Inc. stock2025 Key Lessons & Safe Capital Allocation Plans - newser.com
Chart based analysis of Inovio Pharmaceuticals Inc. trendsM&A Rumor & Growth Oriented Trade Recommendations - newser.com
How to use a screener to detect Inovio Pharmaceuticals Inc. breakoutsJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
How to read the order book for Inovio Pharmaceuticals Inc.Trade Entry Report & Weekly Stock Breakout Alerts - newser.com
How reliable is Inovio Pharmaceuticals Inc. (GBM) stock dividend growthGap Up & Weekly High Conviction Ideas - newser.com
Will Inovio Pharmaceuticals Inc. stock go up soonQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stock2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock reach $200 price targetGold Moves & AI Forecast Swing Trade Picks - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock expand revenue streamsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
Published on: 2025-11-02 06:09:53 - newser.com
Why Inovio Pharmaceuticals Inc. stock appeals to dividend seekers2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Inovio Pharmaceuticals Q3 Earnings Tops Estimates, Lifts Retail Sentiment - MSN
Inovio Pharmaceuticals, Inc. (INO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-11-01 12:25:46 - newser.com
INOVIO’s DNA-Encoded Antibody Trial Shows Durable In Vivo Expression - MyChesCo
Will breakout in Inovio Pharmaceuticals Inc. lead to full recoveryJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Published on: 2025-11-01 02:20:30 - newser.com
What analyst consensus says on Inovio Pharmaceuticals Inc. stockJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Inovio Pharmaceuticals, Inc. (INO.MX) stock price, news, quote and history - Yahoo! Finance UK
INOVIO Reports Inducement Grant Under Inducement Plan - StreetInsider
2025-10-31 | INOVIO Reports Inducement Grant Under Inducement Plan | NDAQ:INO | Press Release - Stockhouse
How Inovio Pharmaceuticals Inc. stock performs in rising dollar environmentEarnings Beat & Verified High Yield Trade Plans - newser.com
Can machine learning forecast Inovio Pharmaceuticals Inc. recoveryTrade Ideas & Daily Oversold Bounce Ideas - newser.com
How risky is Inovio Pharmaceuticals Inc. stock nowBreakout Watch & High Yield Stock Recommendations - newser.com
Will Inovio Pharmaceuticals Inc. benefit from macro trendsM&A Rumor & Short-Term High Return Strategies - newser.com
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):